Sign In
Buy EKSO
$11.80
+0 (+0%)
At Close: Jun 03, 2026
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
08:00am, Monday, 11'th Sep 2023
SAN RAFAEL, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
06:28pm, Thursday, 27'th Jul 2023
Ekso Bionics (EKSO) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.23 per share a year ago.
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
08:00am, Thursday, 20'th Jul 2023
SAN RAFAEL, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript
10:09pm, Thursday, 27'th Apr 2023
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript.
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
08:00am, Thursday, 20'th Apr 2023
SAN RAFAEL, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics Holdings, Inc. (EKSO) Q4 2022 Earnings Call Transcript
06:08pm, Tuesday, 28'th Mar 2023
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations, FINN Partners Scott Davis - Chief Execut
Ekso Bionics Holdings, Inc. (EKSO) Q3 2022 Earnings Call Transcript
11:25am, Sunday, 06'th Nov 2022
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Steven Sherman - Chairman and Chief Exe
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates
07:35pm, Thursday, 03'rd Nov 2022
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
04:05pm, Tuesday, 06'th Sep 2022
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics: Fragile Opportunity
04:34am, Wednesday, 24'th Aug 2022
Ekso Bionics has added a new use case for the EksoNR exoskeleton, multiple sclerosis, opening some new avenues for marginal revenue growth. Pre-Covid, Ekso had started to see sharp improvements in ope
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q2 2022 Results - Earnings Call Transcript
07:53pm, Thursday, 28'th Jul 2022
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q2 2022 Results Conference Call July 28, 2022 4:30 PM ET Company Participants David Carey - Head, Investor Relations Steven Sherman - Chairman & CEO Scott Da
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
06:44pm, Thursday, 28'th Jul 2022
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
08:00am, Thursday, 21'st Jul 2022
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today a
Ekso Bionics (EKSO) Could Find Support Soon, Here's Why You Should Buy the Stock Now
01:55pm, Friday, 13'th May 2022 Zacks Investment Research
Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among W
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates
09:35pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
